• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胃癌的分子病理学]

[Molecular pathology of gastric cancer].

作者信息

Röcken C, Warneke V

机构信息

Institut für Pathologie, Christian-Albrechts-Universität Kiel, Arnold-Heller-Str. 3/14, 24105 Kiel.

出版信息

Pathologe. 2012 Nov;33 Suppl 2:235-40. doi: 10.1007/s00292-012-1634-4.

DOI:10.1007/s00292-012-1634-4
PMID:22983100
Abstract

Gastric cancer is one of the most common cancers worldwide. In recent decades, major advancements in the understanding of the epidemiology, pathology and pathogenesis of gastric cancer have been witnessed. Infections with Helicobacter pylori or Epstein-Barr virus, dietary and lifestyle factors contribute to the risk of developing gastric cancer. With respect to pathogenesis at least three distinct types of gastric cancer exist, (1) proximal, (2) distal diffuse and (3) distal non-diffuse types. Genetic and epigenetic alterations are related to oncogene mutations and tumor suppressor gene inactivation. Canonical oncogenic pathways such as the WNT/β-catenin signaling pathway are de-regulated in gastric cancer. Hereditary and familial type gastric cancers are currently linked to CDH1 gene mutations and various genetic polymorphisms determining disease susceptibility. Molecular subtypes of gastric cancer have been identified which separate diffuse from intestinal type gastric cancer and are not entirely congruent with the histopathological phenotype according to Laurén but may influence chemosensitivity. Putative cancer stem cell markers of gastric cancer have been found (e.g. ADAM17, CD133, FZD7, LGR5) and correlate with patient prognosis. Thus, molecular phenotyping of gastric cancer is still in its infancy and the search for novel diagnostic, prognostic and predictive biomarkers continues.

摘要

胃癌是全球最常见的癌症之一。近几十年来,人们在胃癌的流行病学、病理学和发病机制的认识上取得了重大进展。幽门螺杆菌或爱泼斯坦-巴尔病毒感染、饮食和生活方式因素会增加患胃癌的风险。就发病机制而言,至少存在三种不同类型的胃癌,(1)近端型,(2)远端弥漫型和(3)远端非弥漫型。基因和表观遗传改变与癌基因突变和肿瘤抑制基因失活有关。经典致癌途径如WNT/β-连环蛋白信号通路在胃癌中失调。遗传性和家族性胃癌目前与CDH1基因突变以及决定疾病易感性的各种基因多态性有关。已经确定了胃癌的分子亚型,这些亚型将弥漫型与肠型胃癌区分开来,并且与劳伦(Laurén)的组织病理学表型并不完全一致,但可能影响化疗敏感性。已经发现了胃癌的假定癌症干细胞标志物(例如ADAM17、CD133、FZD7、LGR5),并且与患者预后相关。因此,胃癌的分子表型分析仍处于起步阶段,对新型诊断、预后和预测生物标志物的探索仍在继续。

相似文献

1
[Molecular pathology of gastric cancer].[胃癌的分子病理学]
Pathologe. 2012 Nov;33 Suppl 2:235-40. doi: 10.1007/s00292-012-1634-4.
2
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.CDH1 种系突变患者中遗传性弥漫性胃癌检测标准和结果的准确性。
Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11.
3
Gastric cancer: new genetic developments.胃癌:新的遗传学进展
J Surg Oncol. 2005 Jun 1;90(3):114-33; discussion 133. doi: 10.1002/jso.20214.
4
Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.卷曲蛋白 7 通过激活胃癌中的经典 Wnt/β-连环蛋白通路促进上皮间质转化和干细胞特性。
Int J Biol Sci. 2018 Feb 12;14(3):280-293. doi: 10.7150/ijbs.23756. eCollection 2018.
5
Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.遗传性弥漫性胃癌综合征进展过程中CDH1基因表观遗传和遗传二次打击的定量分析。
Gastroenterology. 2009 Jun;136(7):2137-48. doi: 10.1053/j.gastro.2009.02.065. Epub 2009 Mar 6.
6
Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer.家族性胃癌的分子病理学,重点关注遗传性弥漫性胃癌。
J Clin Pathol. 2008 Jan;61(1):25-30. doi: 10.1136/jcp.2006.043679. Epub 2007 May 18.
7
Gene methylation in gastric cancer.胃癌中的基因甲基化。
Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10.
8
Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.遗传性弥漫性胃癌中原位印戒细胞癌的组织病理学分析。
Am J Surg Pathol. 2020 Sep;44(9):1204-1212. doi: 10.1097/PAS.0000000000001511.
9
[Hereditary diffuse gastric cancer].[遗传性弥漫性胃癌]
Rev Gastroenterol Peru. 2015 Jan;35(1):73-8.
10
Genetics, pathology, and clinics of familial gastric cancer.遗传性胃癌的遗传学、病理学及临床研究
Int J Surg Pathol. 2006 Jan;14(1):21-33. doi: 10.1177/106689690601400105.

引用本文的文献

1
MDM2 amplification is rare in gastric cancer.胃癌中 MDM2 扩增罕见。
Virchows Arch. 2023 Dec;483(6):795-807. doi: 10.1007/s00428-023-03674-8. Epub 2023 Oct 11.
2
Hypericin Induces Apoptosis in AGS Cell Line with No Significant Effect on Normal Cells.金丝桃素诱导AGS细胞系凋亡,对正常细胞无显著影响。
Iran J Pharm Res. 2020 Summer;19(3):349-357. doi: 10.22037/ijpr.2019.14904.12735.
3
Knockdown of Rab9 Suppresses the Progression of Gastric Cancer Through Regulation of Akt Signaling Pathway.敲低Rab9通过调控Akt信号通路抑制胃癌进展。

本文引用的文献

1
Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links.癌症干细胞和上皮-间充质转化:概念和分子联系。
Semin Cancer Biol. 2012 Oct;22(5-6):396-403. doi: 10.1016/j.semcancer.2012.04.001. Epub 2012 Apr 23.
2
The spatial distribution of LGR5+ cells correlates with gastric cancer progression.LGR5+ 细胞的空间分布与胃癌的进展相关。
PLoS One. 2012;7(4):e35486. doi: 10.1371/journal.pone.0035486. Epub 2012 Apr 18.
3
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820915958. doi: 10.1177/1533033820915958.
4
Knockdown of long noncoding RNA GHET1 inhibits cell‑cycle progression and invasion of gastric cancer cells.敲低长非编码 RNA GHET1 抑制胃癌细胞的细胞周期进程和侵袭。
Mol Med Rep. 2018 Sep;18(3):3375-3381. doi: 10.3892/mmr.2018.9332. Epub 2018 Jul 27.
5
Binding of the Helicobacter pylori OipA causes apoptosis of host cells via modulation of Bax/Bcl-2 levels.幽门螺杆菌 OipA 的结合导致宿主细胞通过调节 Bax/Bcl-2 水平发生细胞凋亡。
Sci Rep. 2017 Aug 14;7(1):8036. doi: 10.1038/s41598-017-08176-7.
6
Enhanced expression of long non-coding RNA NEAT1 is associated with the progression of gastric adenocarcinomas.长链非编码RNA NEAT1的表达增强与胃腺癌的进展相关。
World J Surg Oncol. 2016 Feb 24;14(1):41. doi: 10.1186/s12957-016-0799-3.
7
Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion.造血前B细胞白血病转录因子相互作用蛋白在胃癌中过表达,并促进胃癌细胞的增殖、迁移和侵袭。
Cancer Sci. 2015 Oct;106(10):1313-22. doi: 10.1111/cas.12754. Epub 2015 Sep 25.
胃腺癌外显子组测序鉴定细胞黏附与染色质重塑基因中的重现性体细胞突变。
Nat Genet. 2012 May;44(5):570-4. doi: 10.1038/ng.2246.
4
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.胃癌中基因组改变的全面调查揭示了不同治疗靶点之间分子排他性和共同发生的系统模式。
Gut. 2012 May;61(5):673-84. doi: 10.1136/gutjnl-2011-301839. Epub 2012 Feb 7.
5
Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice.幽门螺杆菌感染招募骨髓来源的细胞,这些细胞参与小鼠胃的前期病变。
Gastroenterology. 2012 Feb;142(2):281-91. doi: 10.1053/j.gastro.2011.10.036. Epub 2011 Nov 4.
6
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome.胃腺癌和胃近端息肉病(GAPPS):一种新的常染色体显性综合征。
Gut. 2012 May;61(5):774-9. doi: 10.1136/gutjnl-2011-300348. Epub 2011 Aug 3.
7
Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.胃癌中表皮生长因子受体(HER)改变的预后意义:HER2 和 HER3 是不良预后的预测因子。
J Clin Oncol. 2011 Aug 1;29(22):3030-6. doi: 10.1200/JCO.2010.33.6313. Epub 2011 Jun 27.
8
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.基于基因表达模式的胃癌内在亚型可预测生存并对化疗有不同的反应。
Gastroenterology. 2011 Aug;141(2):476-85, 485.e1-11. doi: 10.1053/j.gastro.2011.04.042. Epub 2011 Apr 28.
9
Genotypic and phenotypic characterization of side population of gastric cancer cell lines.胃癌细胞系侧群的基因表型特征分析。
Am J Pathol. 2011 Apr;178(4):1792-804. doi: 10.1016/j.ajpath.2010.12.043.
10
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.曲妥珠单抗联合化疗与单纯化疗治疗 HER2 阳性晚期胃或胃食管交界腺癌(ToGA):一项开放标签、随机对照的 3 期临床试验。
Lancet. 2010 Aug 28;376(9742):687-97. doi: 10.1016/S0140-6736(10)61121-X. Epub 2010 Aug 19.